Autoantibodies to β2-glycoprotein I (β2GPI) are believed to be the primary cause of
coagulation abnormalities in patients with antiphospholipid syndrome (APS). Clinical …

Antiphospholipid Syndrome (APS) is characterized by vascular thrombosis and/or
pregnancy morbidity occurring in patients with persistent antiphospholipid antibodies (aPL) …

Antiphospholipid syndrome (APS) is a hypercoagulable state characterized by arterial and
venous thromboses and pregnancy morbidity in the presence of antiphospholipid …

The antiphospholipid syndrome (APS) is an autoimmune disease in which recurrent
vascular thrombosis, pregnancy morbidity or a combination of these events is associated …

Antiphospholipid syndrome (APS) is a systemic, autoimmune disorder characterized by the
presence of antiphospholipid antibodies (APLA) directed to various plasma proteins bound …

Publisher Summary Antiphospholipid (aPL) antibodies are found in normal individuals, and
can be divided into two main groups, classified according to their association with …

The availability of animal models of the APS has provided a lot of experimental data which
might be considered in trying to unravel several questions concerning this complicated …

The presence of antiphospholipid antibodies in plasma is a risk factor for thromboembolic
complications. In vitro, however, the same antibodies can prolong clotting times in …

The presence of antiphospholipid antibodies (aPL) is essential to diagnose the
antiphospholipid syndrome (APS). Three assays are available to detect the presence of …

For more than a decade the antiphospholipid syndrome (APS) has been reported to be
caused mainly by antiphospholipid antibodies (aPL), which are not directed against …